Miguel Á Tejada (Miguel A Tejada)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Neuropathic Pain

Epidermal Growth Factor Receptor

Top Venues

Science translational medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Á Tejada, Ana I Santos-Llamas, Lesley Escriva, Juan J Tarin, Antonio Cano, Maria J Fernández-Ramírez, Paulina Nunez-Badinez, Bianca De Leo, Philippa T K Saunders, Victor Vidal, Florent Barthas, Katy Vincent, Patrick J Sweeney, Rowland R Sillito, James Douglas Armstrong, Jens Nagel, Raúl Gomez
Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain. Biomedicines 10 (2) (2022)
Shane J F Cronin, Shuan Rao, Miguel Á Tejada, Bruna Lenfers Turnes, Simon Licht-Mayer, Takao Omura, Christian Brenneis, Emily Jacobs, Lee Barrett, Alban Latremoliere, Nick Andrews, Keith M Channon, Alexandra Latini, Anthony C Arvanites, Lance S Davidow, Michael Costigan, Lee L Rubin, Josef M Penninger, Clifford J Woolf
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer. Science translational medicine 14 (660) (2022)
Raúl Gomez, Miguel Á Tejada, Víctor Rodríguez-García, Octavio Burgués, Ana I Santos-Llamas, Andrea Martínez-Massa, Antonio Marín-Montes, Juan J Tarín, Antonio Cano
Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers. International journal of molecular sciences 23 (3) (2022)
Rafael González-Cano, M Carmen Ruiz-Cantero, Miriam Santos-Caballero, Carlos Gómez-Navas, Miguel Á Tejada, Francisco R Nieto
Tetrodotoxin, a Potential Drug for Neuropathic and Cancer Pain Relief? Toxins 13 (7) (2021)